BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tharwat M, Tawheed A, El-Kassas M. Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies. World J Clin Cases 2025; 13(9): 99043 [PMID: 40144486 DOI: 10.12998/wjcc.v13.i9.99043]
URL: https://www.wjgnet.com/2307-8960/full/v13/i9/99043.htm
Number Citing Articles
1
Atezolizumab/Bevacizumab. Reactions Weekly 2026; 2128(1) doi: 10.1007/s40278-026-98031-z